No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8
Similar endpoints
↥List of similar endpoints to
Marginal zone B-cell lymphoma
based on the number of shared cases.
Similar with more cases:
- Marginal zone B-cell lymphoma
- Malignant neoplasm
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1520 | 860 | 648 |
| Only index persons | 1227 | 714 | 513 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 68.84 | 69.41 | 68.06 |
| Only index persons | 68.33 | 68.62 | 67.93 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 256 | 125 | 131 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 64.90 | 63.33 | 66.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
Mortality – FinRegistry
↥Association
Association between endpoint C3_MARGINAL_ZONE_LYMPHOMA_EXALLC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| C3_MARGINAL_ZONE_LYMPHOMA_EXALLC | 1.707 [1.35, 2.16] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.179 |
During the follow-up period (1.1.1998 — 31.12.2019), 174 out of 612 females with C3_MARGINAL_ZONE_LYMPHOMA_EXALLC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| C3_MARGINAL_ZONE_LYMPHOMA_EXALLC | 1.625 [1.21, 2.19] | 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 435 males with C3_MARGINAL_ZONE_LYMPHOMA_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_MARGINAL_ZONE_LYMPHOMA_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.152% | 0.287% |
| 5 | 0.949% | 2.002% |
| 10 | 2.455% | 5.085% |
| 15 | 4.484% | 9.493% |
| 20 | 7.689% | 15.684% |
Relationships between endpoints
↥Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA_EXALLC – Marginal zone B-cell lymphoma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data